secwatch.observer — SEC 8-K summary
======================================

Issuer:     Candel Therapeutics, Inc. (CADL)
CIK:        0001841387
Form:       8-K
Filed at:   2022-08-01T23:59:59+00:00
Accession:  0001193125-22-207610
Event type: leadership
Sentiment:  neutral
Materiality: 0.45
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Candel Therapeutics appoints 3 new directors; 3 resign effective Aug 8, 2022
----------------------------------------------------------------------------

- Renee Gaeta, Gary Nabel, and Joseph Papa join the board, replacing Alan Smith, Shaan Gandhi, and Udi Meirav.
- Gaeta is CFO of Eko Devices; Nabel is CEO of ModeX Therapeutics; Papa is CEO of Bausch + Lomb.
- Resignations were not due to any disagreement with the company on operations, policies, or practices.
- New directors each receive option to purchase 28,480 shares vesting over 3 years and standard cash compensation.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/0001193125-22-207610-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1841387/000119312522207610/d353433d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-207610

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer